Neurology Updates

The COVID 19 pandemic has affected people with neurological disease and reduced the care provided, with possible adverse sequelae, including frailty.

A new study has shown that a short-term palliative care intervention was seen positively by the patients and families and reduced costs, but did not…

Siponimod has been associated with decrease in HR at treatment initiation and development of hypertension during treatment, which may be predicted by…

Pain management, covid-19 pandemic, recommendations

Rotigotine in patients with mild to moderate Alzheimer disease may have a potential effect in reducing frontal lobe cognitive dysfunction and in…

Telemedicine consultations can aid effective epilepsy care, even for first visits.

Caution is warranted with the use of antiseizure medications in the context of COVID-19 illness.

This neurology update focuses on mental well-being of people with epilepsy and their caregivers during the COVID-19 pandemic.

Highet B, Dieriks BV, Murray HC, Faull RLM and Curtis MA (2020)

Huntingtin Aggregates in the Olfactory Bulb in Huntington’s Disease. Front. Aging…

Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis.

www.pnas.org/cgi/doi/10.1073/pnas.2003798117 …

The International Restless Legs Syndrome Study Group task force found sufficient evidence to formulate diagnostic criteria for pediatric clinical…

Dementia Lewy bodies (DLB) may present in the prodromal stage as mild cognitive impairment, delirium-onset or psychiatric-onset and authors proposed…